AM 251

  ( 165 citations )    
Product Datasheet
Catalog Number:1117
Chemical Name:N-(Piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide
Product Details
Citations (165)
Supplemental Products
Reviews
Citations:

The citations listed below are publications that use Tocris products. Selected citations for AM 251 include:

165 Citations: Showing 1 - 10
Filter your results:

  1. Feeding induced by cannabinoids is mediated independently of the melanocortin system.
    Authors: Sinnayah Et al.
    Proc Natl Acad Sci U S A  ;3:e2202
  2. The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system.
    Authors: Kola Et al.
    Br J Pharmacol  ;3:e1797
  3. Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex.
    Authors: Lafourcade Et al.
    PLoS One  ;2:e709
  4. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.
    Authors: Jiang Et al.
    PLoS One  ;2:e641
  5. Involvement of cannabinoid system in the nucleus accumbens on delay-based decision making in the rat.
    Authors: Fatahi
    Behav Brain Res.  2017;337:107
  6. Cannabinoid receptor 1 contributes to sprouted innervation in endometrial ectopic growth through mitogen-activated protein kinase activation.
    Authors: Han
    Brain Res  2017;1663:132
  7. AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity.
    Authors: Saliba
    J Neuroinflammation  2017;14(1):246
  8. AMPK contributes to aerobic exercise-induced antinociception downstream of endocannabinoids.
    Authors: King-Himmelreich
    Neuropharmacology  2017;124:134
  9. Orphan nuclear receptor ERRγ is a key regulator of human fibrinogen gene expression.
    Authors: Zhang
    PLoS One  2017;12(7):e0182141
  10. Endocannabinoid dynamics gate spike-timing dependent depression and potentiation.
    Authors: Cui Et al.
    Elife  2016;5:e13185
  11. Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment.
    Authors: Krohn Et al.
    J Inflamm (Lond)  2016;13:21
  12. Impaired Excitatory Neurotransmission in the Urinary Bladder from the Obese Zucker Rat: Role of Cannabinoid Receptors.
    Authors: Blaha Et al.
    PLoS One  2016;11:e0157424
  13. Δ 9-Tetrahydrocannabinol Reverses TNFα-induced Increase in Airway Epithelial Cell Permeability through CB 2 Receptors
    Authors: Shang Et al.
    Biochemical Pharmacology  2016;
  14. Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal Cortex.
    Authors: Martin Et al.
    Br J Pharmacol  2015;9:457
  15. Tonic endocannabinoid-mediated modulation of GABA release is independent of the CB1 content of axon terminals.
    Authors: Lenkey Et al.
    Sci Rep  2015;6:6557
  16. FAAH genetic variation enhances fronto-amygdala function in mouse and human.
    Authors: Dincheva Et al.
    Nat Commun  2015;6:6395
  17. Regional effects of endocannabinoid, BDNF and FGF receptor signalling on neuroblast motility and guidance along the rostral migratory stream.
    Authors: Zhou Et al.
    Nat Commun  2015;64:32
  18. Role of the endocannabinoid system in obesity induced by neuropeptide Y overexpression in noradrenergic neurons.
    Authors: Vähätalo Et al.
    Mol Cell Neurosci  2015;5:e151
  19. Differential immune mechanism to HIV-1 Tat variants and its regulation by AEA [corrected].
    Authors: Krishnan and Chatterjee
    PLoS One  2015;5:9887
  20. Involvement of GluR2 up-regulation in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptor in mice.
    Authors: Liu Et al.
    Nutr Diabetes  2015;5:9490
  21. Coadministration of indomethacin and minocycline attenuates established paclitaxel-induced neuropathic thermal hyperalgesia: Involvement of cannabinoid CB1 receptors.
    Authors: Parvathy and Masocha
    J Neurosci  2015;5:10541
  22. Activation of cannabinoid receptor 1 inhibits increased bladder activity induced by nerve growth factor.
    Authors: Wang Et al.
    Neurosci Lett  2015;589:19
  23. Cannabinoid receptor CB2 is involved in tetrahydrocannabinol-induced anti-inflammation against lipopolysaccharide in MG-63 cells.
    Authors: Yang Et al.
    Sci Rep  2015;2015:362126
  24. Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures.
    Authors: Malek Et al.
    Neural Plast  2015;2015:130639
  25. Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation.
    Authors: Bashashati Et al.
    Br J Pharmacol  2015;172:3099
  26. A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome.
    Authors: Bowles Et al.
    Mol Pharmacol  2015;112:285
  27. Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle.
    Authors: Arrabal Et al.
    PLoS One  2015;10:e0145244
  28. Anoctamin Calcium-Activated Chloride Channels May Modulate Inhibitory Transmission in the Cerebellar Cortex.
    Authors: Zhang Et al.
    PLoS One  2015;10:e0142160
  29. The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation.
    Authors: Smith Et al.
    Proc Natl Acad Sci U S A  2015;10:e0136546
  30. Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation.
    Authors: Stanley Et al.
    Front Cell Neurosci  2015;107:568
  31. Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling.
    Authors: Alpár Et al.
    J Neurosci  2014;5:4421
  32. Presynaptic calcium channel inhibition underlies CB1 cannabinoid receptor-mediated suppression of GABA release.
    Authors: Szabó Et al.
    Mediators Inflamm  2014;34:7958
  33. Hippocampal metaplasticity is required for the formation of temporal associative memories.
    Authors: Xu Et al.
    J Neurosci  2014;34:16762
  34. Miswiring the brain: △9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway.
    Authors: Tortoriello Et al.
    Proc Natl Acad Sci U S A  2014;33:668
  35. CB1 cannabinoid receptor stimulation during adolescence impairs the maturation of GABA function in the adult rat prefrontal cortex.
    Authors: Cass Et al.
    Mol Psychiatry  2014;19:536
  36. CB1 cannabinoid receptors are involved in neuroleptic-induced enhancement of brain neurotensin.
    Authors: Hassanzadeh and Rostami
    J Neurosci  2014;17:181
  37. Effects of the endogenous cannabinoid anandamide on voltage-dependent sodium and calcium channels in rat ventricular myocytes.
    Authors: Kury Et al.
    Br J Pharmacol  2014;171:3485
  38. 2-arachidonoylglycerol effects in cytotrophoblasts: metabolic enzymes expression and apoptosis in BeWo cells.
    Authors: Costa Et al.
    Reproduction  2014;147:301
  39. Expression and functional relevance of cannabinoid receptor 1 in Hodgkin lymphoma.
    Authors: Benz Et al.
    PLoS One  2013;8:e81675
  40. Hepatic cannabinoid receptor type 1 mediates alcohol-induced regulation of bile acid enzyme genes expression via CREBH.
    Authors: Chanda Et al.
    PLoS One  2013;8:e68845
  41. Cannabinoid HU210 protects isolated rat stomach against impairment caused by serum of rats with experimental acute pancreatitis.
    Authors: Cao Et al.
    PLoS One  2013;7:e52921
  42. The cannabinoid δ(9)-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity.
    Authors: Wargent Et al.
    Nutr Diabetes  2013;3:e68
  43. Diacylglycerol lipase α manipulation reveals developmental roles for intercellular endocannabinoid signaling.
    Authors: Keimpema Et al.
    Nat Commun  2013;3:2093
  44. Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory.
    Authors: Abush and Akirav
    Neuropsychopharmacology  2013;38:1521
  45. Cannabinoid 1 receptors are critical for the innate immune response to TLR4 stimulation.
    Authors: Duncan Et al.
    Am J Physiol Regul Integr Comp Physiol  2013;305:R224
  46. CB1 cannabinoid receptors couple to focal adhesion kinase to control insulin release.
    Authors: Malenczyk Et al.
    J Biol Chem  2013;288:32685
  47. Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells.
    Authors: Li Et al.
    Br J Pharmacol  2013;170:489
  48. Gene-environment interactions affect long-term depression (LTD) through changes in dopamine receptor affinity in Snap25 deficient mice.
    Authors: Baca Et al.
    Brain Res  2013;1532:85
  49. Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors.
    Authors: Hayase
    BMC Neurosci  2013;14:20
  50. The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells.
    Authors: Sreevalsan and Safe
    Mol Cancer Ther  2013;12:2483
  51. Salvinorin A reduces mechanical allodynia and spinal neuronal hyperexcitability induced by peripheral formalin injection.
    Authors: Guida Et al.
    Mol Pain  2012;8:60
  52. Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.
    Authors: Brents Et al.
    Biochem Pharmacol  2012;83:952
  53. Regulation of MMP-9 by a WIN-binding site in the monocyte-macrophage system independent from cannabinoid receptors.
    Authors: Tauber Et al.
    PLoS One  2012;7:e48272
  54. CB1 receptor autoradiographic characterization of the individual differences in approach and avoidance motivation.
    Authors: Laricchiuta Et al.
    PLoS One  2012;7:e42111
  55. A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation.
    Authors: Tozzi Et al.
    PLoS One  2012;7:e38312
  56. Differences in spontaneously avoiding or approaching mice reflect differences in CB1-mediated signaling of dorsal striatal transmission.
    Authors: Laricchiuta Et al.
    PLoS One  2012;7:e33260
  57. A Role for the Cannabinoid 1 Receptor in Neuronal Differentiation of Adult Spinal Cord Progenitors in vitro is Revealed through Pharmacological Inhibition and Genetic Deletion.
    Authors: Sideris Et al.
    Front Neurosci  2012;6:4
  58. Opposing roles for cannabinoid receptor type-1 (CB1) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats.
    Authors: Casarotto Et al.
    Pain  2012;37:478
  59. Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress.
    Authors: Ganon-Elazar and Akirav
    Neuropsychopharmacology  2012;37:456
  60. On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment.
    Authors: Stern Et al.
    Neuropsychopharmacology  2012;37:2132
  61. Endocannabinoid-mediated long-term depression of afferent excitatory synapses in hippocampal pyramidal cells and GABAergic interneurons.
    Authors: Peterfi Et al.
    J Neurosci  2012;32:14448
  62. Tonic and transient endocannabinoid regulation of AMPAergic miniature postsynaptic currents and homeostatic plasticity in embryonic motor networks.
    Authors: Gonzalez-Islas Et al.
    Sci Rep  2012;32:13597
  63. Developmental regulation of CB1-mediated spike-time dependent depression at immature mossy fiber-CA3 synapses.
    Authors: Caiati Et al.
    Sci Rep  2012;2:285
  64. Activation of cannabinoid receptor type 1 (Cb1r) disrupts hepatic insulin receptor signaling via cyclic AMP-response element-binding protein H (Crebh)-mediated induction of Lipin1 gene.
    Authors: Chanda Et al.
    Br J Pharmacol  2012;287:38041
  65. Repeated morphine treatment-mediated hyperalgesia, allodynia and spinal glial activation are blocked by co-administration of a selective cannabinoid receptor type-2 agonist.
    Authors: Tumati Et al.
    J Neuroimmunol  2012;244:23
  66. TRPV1-dependent and -independent alterations in the limbic cortex of neuropathic mice: impact on glial caspases and pain perception.
    Authors: Giordano Et al.
    Cereb Cortex  2012;22:2495
  67. Cannabinoid CB(2) receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide.
    Authors: Merighi Et al.
    Br J Pharmacol  2012;165:1773
  68. Effects of gonadal hormones on the peripheral cannabinoid receptor 1 (CB1R) system under a myositis condition in rats.
    Authors: Niu Et al.
    J Pharmacol Exp Ther  2012;153:2283
  69. Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer.
    Authors: Liu Et al.
    Mol Cancer Ther  2012;11:1421
  70. The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats.
    Authors: Novellis Et al.
    Mol Pain  2011;7:7
  71. The antinociceptive effects of JWH-015 in chronic inflammatory pain are produced by nitric oxide-cGMP-PKG-KATP pathway activation mediated by opioids.
    Authors: Negrete Et al.
    PLoS One  2011;6:e26688
  72. Acute overactive endocannabinoid signaling induces glucose intolerance, hepatic steatosis, and novel cannabinoid receptor 1 responsive genes.
    Authors: Ruby Et al.
    PLoS One  2011;6:e26415
  73. Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity.
    Authors: Brents Et al.
    PLoS One  2011;6:e21917
  74. Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB1 receptor blockade.
    Authors: Crespillo Et al.
    Biochem J  2011;433:175
  75. Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of δ9-tetrahydrocannabinol on spatial memory.
    Authors: Sousa Et al.
    Neuropsychopharmacology  2011;36:472
  76. Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice.
    Authors: Pan Et al.
    J Cell Biol  2011;31:13420
  77. Associative, bidirectional changes in neural signaling utilizing NMDA receptor- and endocannabinoid-dependent mechanisms.
    Authors: Li and Burrell
    Learn Mem  2011;18:545
  78. Differential effects of cannabinoid receptor agonist on social discrimination and contextual fear in amygdala and hippocampus.
    Authors: Segev and Akirav
    Learn Mem  2011;18:254
  79. The Role of the Endocannabinoids in Suppression of the Hypothalamic-pituitary-adrenal Axis Activity by Doxepin.
    Authors: Hassanzadeh and Hassanzadeh
    J Leukoc Biol  2011;14:414
  80. Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine.
    Authors: Guidali Et al.
    Int J Neuropsychopharmacol  2011;14:17
  81. Post-ictal analgesia in genetically epilepsy-prone rats is induced by audiogenic seizures and involves cannabinoid receptors in the periaqueductal gray.
    Authors: Samineni Et al.
    Brain Res  2011;1389:177
  82. Endocannabinoids mediate synaptic plasticity at glutamatergic synapses on spiny neurons within a basal ganglia nucleus necessary for song learning.
    Authors: Thompson and Perkel
    J Neurophysiol  2011;105:1159
  83. The maturation of GABAergic transmission in visual cortex requires endocannabinoid-mediated LTD of inhibitory inputs during a critical period.
    Authors: Jiang Et al.
    Neuron  2010;66:248
  84. THC Prevents MDMA Neurotoxicity in Mice.
    Authors: Touriño Et al.
    PLoS One  2010;5:e9143
  85. The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages.
    Authors: Hao Et al.
    Iran J Basic Med Sci  2010;51:2181
  86. Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.
    Authors: Jones Et al.
    Cereb Cortex  2010;332:569
  87. A putative 'pre-nervous' endocannabinoid system in early echinoderm development.
    Authors: Buznikov Et al.
    Dev Neurosci  2010;32:1
  88. A refractory period for rejuvenating GABAergic synaptic transmission and ocular dominance plasticity with dark exposure.
    Authors: Huang Et al.
    J Neurosci  2010;30:16636
  89. Repeated stress impairs endocannabinoid signaling in the paraventricular nucleus of the hypothalamus.
    Authors: Wamsteeker Et al.
    J Neurosci  2010;30:11188
  90. Cannabinoids excite circadian clock neurons.
    Authors: Acuna-Goycolea Et al.
    J Neurosci  2010;30:10061
  91. Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy.
    Authors: Bhaskaran and Smith
    Endocrinology  2010;223:529
  92. Interaction between anandamide and sphingosine-1-phosphate in mediating vasorelaxation in rat coronary artery.
    Authors: Mair Et al.
    Br J Pharmacol  2010;161:176
  93. Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex.
    Authors: Ho Et al.
    Neuropsychopharmacology  2010;160:736
  94. GPR55 ligands promote receptor coupling to multiple signalling pathways.
    Authors: Henstridge Et al.
    Br J Pharmacol  2010;160:604
  95. Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain.
    Authors: Curto-Reyes Et al.
    Br J Pharmacol  2010;160:561
  96. Retrograde endocannabinoid signaling reduces GABAergic synaptic transmission to gonadotropin-releasing hormone neurons.
    Authors: Farkas Et al.
    J Biol Chem  2010;151:5818
  97. Regulation of the hypothalamic-pituitary-adrenal axis circadian rhythm by endocannabinoids is sexually diergic.
    Authors: Atkinson Et al.
    Endocrinology  2010;151:3720
  98. Network mechanisms of theta related neuronal activity in hippocampal CA1 pyramidal neurons.
    Authors: Losonczy Et al.
    Nat Neurosci  2010;13:967
  99. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system.
    Authors: Schlosburg Et al.
    Nat Neurosci  2010;13:1113
  100. Endocannabinoid-dependent LTD in a nociceptive synapse requires activation of a presynaptic TRPV-like receptor.
    Authors: Yuan and Burrell
    J Neurophysiol  2010;104:2766
  101. Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine.
    Authors: Garzón Et al.
    Mol Pain  2009;5:11
  102. PKCε regulates behavioral sensitivity, binding and tolerance to the CB1 receptor agonist WIN55,212-2.
    Authors: Wallace Et al.
    Iran J Basic Med Sci  2009;34:1733
  103. The neuroprotective impact of the leak potassium channel TASK1 on stroke development in mice.
    Authors: Meuth Et al.
    Exp Neurol  2009;33:42675
  104. Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling.
    Authors: Pan Et al.
    J Pharmacol Exp Ther  2009;331:591
  105. Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor.
    Authors: Pacheco Et al.
    Br J Pharmacol  2009;158:225
  106. Effect of the CB(1) receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices.
    Authors: Mendiguren and Pineda
    Br J Pharmacol  2009;158:1579
  107. Endogenous cannabinoids induce fever through the activation of CB1 receptors.
    Authors: Fraga Et al.
    Neuropsychopharmacology  2009;157:1494
  108. Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats.
    Authors: Ho and Gardiner
    Br J Pharmacol  2009;156:94
  109. Processing cardiovascular information in the vlPAG during electroacupuncture in rats: roles of endocannabinoids and GABA.
    Authors: Tjen-A-Looi Et al.
    J Appl Physiol (1985)  2009;106:1793
  110. Altered GABAergic neurotransmission is associated with increased kainate-induced seizure in prostaglandin-endoperoxide synthase-2 deficient mice.
    Authors: Toscano Et al.
    Brain Res Bull  2008;75:598
  111. Analysis of promoter regions regulating basal and interleukin-4-inducible expression of the human CB1 receptor gene in T lymphocytes.
    Authors: Börner Et al.
    Eur J Pharmacol  2008;73:1013
  112. Unique agonist-bound cannabinoid CB1 receptor conformations indicate agonist specificity in signaling.
    Authors: Georgieva Et al.
    Br J Pharmacol  2008;581:19
  113. TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons.
    Authors: Gibson Et al.
    Neuron  2008;57:746
  114. Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception.
    Authors: Wilson Et al.
    Neuropharmacology  2008;55:1219
  115. Cannabinoid receptor activation in the nucleus tractus solitaries produces baroreflex-like responses in the rat.
    Authors: Durakoglugil and Orer
    Int J Biomed Sci  2008;4:229
  116. Dichotomous dopaminergic control of striatal synaptic plasticity.
    Authors: Shen Et al.
    Science  2008;321:848
  117. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors.
    Authors: Melis Et al.
    J Neurosci  2008;28:13985
  118. Electroacupuncture of 2?hz has a rewarding effect: evidence from a conditioned place preference study in rats.
    Authors: Xia Et al.
    Evid Based Complement Alternat Med  2008;2011:730514
  119. Modulation of the anti-nociceptive effects of 2-arachidonoyl glycerol by peripherally administered FAAH and MGL inhibitors in a neuropathic pain model.
    Authors: Desroches Et al.
    Eur J Neurosci  2008;155:913
  120. MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models.
    Authors: Naguib Et al.
    Br J Pharmacol  2008;155:1104
  121. Activation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs.
    Authors: Giannini Et al.
    Br J Pharmacol  2008;12:2381
  122. The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms.
    Authors: Potenzieri Et al.
    Brain Res  2008;1215:69
  123. Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins.
    Authors: Ruby Et al.
    Proc Natl Acad Sci U S A  2008;105:14561
  124. Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis.
    Authors: Rajesh Et al.
    Cardiovasc Res  2007;82:1382
  125. The differential contractile responses to capsaicin and anandamide in muscle strips isolated from the rat urinary bladder.
    Authors: Saitoh Et al.
    J Neurosci  2007;570:182
  126. Potentiation of electrical and chemical synaptic transmission mediated by endocannabinoids.
    Authors: Cachope Et al.
    Neuron  2007;56:1034
  127. Calcium release from presynaptic internal stores is required for ethanol to increase spontaneous γ-aminobutyric acid release onto cerebellum Purkinje neurons.
    Authors: Kelm Et al.
    PLoS One  2007;323:356
  128. Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats.
    Authors: Bátkai Et al.
    Br J Pharmacol  2007;293:H1689
  129. Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexin neurons: implications for cannabinoid actions on food intake and cognitive arousal.
    Authors: Huang Et al.
    J Neurosci  2007;27:4870
  130. Involvement of nitric oxide in depolarization-induced suppression of inhibition in hippocampal pyramidal cells during activation of cholinergic receptors.
    Authors: Makara Et al.
    J Neurosci  2007;27:10211
  131. Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons.
    Authors: Fortin and Levine
    J Biol Chem  2007;17:163
  132. Role of the nitric oxide pathway and the endocannabinoid system in neurogenic relaxation of corpus cavernosum from biliary cirrhotic rats.
    Authors: Ghasemi Et al.
    EMBO J  2007;151:591
  133. Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation.
    Authors: Hoffman Et al.
    Learn Mem  2007;14:63
  134. Cannabinoid action in the olfactory epithelium.
    Authors: Czesnik Et al.
    Proc Natl Acad Sci U S A  2007;104:2967
  135. Deprivation-induced synaptic depression by distinct mechanisms in different layers of mouse visual cortex.
    Authors: Crozier Et al.
    Proc Natl Acad Sci U S A  2007;104:1383
  136. Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons.
    Authors: Wang Et al.
    Neuron  2006;50:443
  137. Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils.
    Authors: Kurihara Et al.
    Br J Pharmacol  2006;281:12908
  138. Vanilloid-mediated heterosynaptic facilitation of inhibitory synaptic input to neurons of the rat dorsal motor nucleus of the vagus.
    Authors: Derbenev Et al.
    PLoS One  2006;26:9666
  139. Two coincidence detectors for spike timing-dependent plasticity in somatosensory cortex.
    Authors: Bender Et al.
    J Neurosci  2006;26:4166
  140. Differential effect of cannabinoid agonists and endocannabinoids on histamine release from distinct regions of the rat brain.
    Authors: Cenni Et al.
    Eur J Neurosci  2006;24:1633
  141. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors.
    Authors: Moezi Et al.
    J Neurosci  2006;149:898
  142. Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models.
    Authors: Jayamanne Et al.
    J Neurosci  2006;147:281
  143. Effects of intra-amygdala infusion of CB1 receptor agonists on the reconsolidation of fear-potentiated startle.
    Authors: Lin Et al.
    Learn Mem  2006;13:316
  144. Amnestic effect of intrahippocampal AM251, a CB1-selective blocker, in the inhibitory avoidance, but not in the open field habituation task, in rats.
    Authors: de Oliveira Alvares Et al.
    Neurobiol Learn Mem  2005;83:119
  145. Endocannabinoids control the induction of cerebellar LTD.
    Authors: Safo and Regehr
    Neuron  2005;48:647
  146. Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase.
    Authors: Pacher Et al.
    J Lipid Res  2005;289:H533
  147. Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus.
    Authors: Hoffman Et al.
    Am J Physiol Heart Circ Physiol  2005;22:2387
  148. Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.
    Authors: Gaskari Et al.
    Sci Rep  2005;146:315
  149. Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor.
    Authors: Berghuis Et al.
    Neurobiol Dis  2005;102:19115
  150. Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice.
    Authors: Jin Et al.
    Am J Physiol Heart Circ Physiol  2004;66:204
  151. Endocannabinoid-mediated metaplasticity in the hippocampus.
    Authors: Chevaleyre and Castillo
    Neuron  2004;43:871
  152. The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of Guinea pig mast cells: involvement of nitric oxide and eicosanoids.
    Authors: Vannacci Et al.
    J Pharmacol Exp Ther  2004;311:256
  153. Electrical coupling among irregular-spiking GABAergic interneurons expressing cannabinoid receptors.
    Authors: Galarreta Et al.
    J Pharmacol Exp Ther  2004;24:9770
  154. Endocannabinoid-independent retrograde signaling at inhibitory synapses in layer 2/3 of neocortex: involvement of vesicular glutamate transporter 3.
    Authors: Harkany Et al.
    Circulation  2004;24:4978
  155. Metabotropic regulation of intrinsic excitability by synaptic activation of kainate receptors.
    Authors: Melyan Et al.
    J Neurosci  2004;24:4530
  156. Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons.
    Authors: Price Et al.
    Br J Pharmacol  2004;142:257
  157. Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors.
    Authors: Akerman Et al.
    Br J Pharmacol  2004;142:1354
  158. Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats.
    Authors: Mathison Et al.
    Br J Pharmacol  2004;142:1247
  159. Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.
    Authors: Bátkai Et al.
    Eur J Pharmacol  2004;110:1996
  160. The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen.
    Authors: Scorticati Et al.
    Mol Pharmacol  2004;101:11891
  161. The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response.
    Authors: Williams Et al.
    J Cell Mol Med  2003;160:481
  162. An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors.
    Authors: Savinainen Et al.
    Br J Pharmacol  2003;140:1451
  163. Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts.
    Authors: Ford Et al.
    Br J Pharmacol  2002;135:1191
  164. Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes.
    Authors: Savinainen Et al.
    Br J Pharmacol  2001;134:664
  165. Identification of two distinct vasodilator pathways activated by ATP in the mesenteric bed of the rat.
    Authors: Stanford Et al.
    Br J Pharmacol  2001;133:825
Expand to show all Citations

FAQs

No product specific FAQs exist for this product, however you may

View all Small Molecule FAQs

Have you used AM 251?

Submit a review and receive a $25US/€18/£15/$25CAN amazon gift card if you include an image - $10US/€7/£6/$10CAN Amazon card for reviews without an image. Limited to verified customers in USA, Canada and Europe.

Tocris Bioscience is the leading supplier of novel and exclusive tools for life science research with over 30 years' experience in the industry. Tocris is a Bio-Techne brand.

Order Details

Contact Us to Order
reload

Feedback

Customer Information
Calculators

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

R&D Systems Guarantee